BGLC

BioNexus Gene LabF

Nasdaq / Capital Goods

At close

2026-06-02

View Chart

Current thesis

Composite grade F from latest DB weights. Momentum 23.4 / Value 35.1

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.0.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-06-02

Fundamentals

As of 2026-06-02 • Vendor: Data Vendor v1

Scores

As of 2026-06-02 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-06-02

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net Neutral

Why

Momentum23 · Δ7d -

Value35 · Δ7d -0.0

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Value · See fundamentals

Momentum

52% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

48% active weight

Current posture

7d trendFlat

Δ7d

-0.0

Δ21d

+1.7

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade F. Momentum 23.4 / Value 35.1

Fundamentals (TTM)

As of 2026-06-02

Market Cap

$5.56M

Beta

2.28

Shares Out

2.36M

P/E (TTM) · Derived

-2.6

P/S (TTM)

1.02

P/FCF (TTM) · Derived

-1.53

Rev YoY

-3.3%

EPS YoY

+47.3%

Gross Margin

+14.8%

Op Margin

-24.8%

Net Debt

-$1.58M

Current Ratio

8.30

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology